The global Gene Silencing Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Product & Service (Products, Services), By Application (Drug Discovery & Development, Therapeutics Manufacturing, Agricultural Applications, Others), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others).
The Gene Silencing Market is expanding rapidly due to advancements in RNA interference (RNAi) and CRISPR-based technologies. Gene silencing, which involves inhibiting the expression of specific genes, has emerged as a promising therapeutic approach for treating genetic disorders, cancer, and viral infections. The rising prevalence of rare diseases and the increasing adoption of targeted therapies are driving market demand. However, challenges such as delivery efficiency, immune response concerns, and regulatory hurdles hinder widespread application. Breakthroughs in lipid nanoparticle carriers, antisense oligonucleotides (ASOs), and small interfering RNA (siRNA) technologies are improving therapeutic efficacy and expanding market potential. With growing investments in precision medicine, personalized treatments, and biotech R&D, the gene silencing market is expected to witness significant growth, particularly in North America and Europe.
The market report analyses the leading companies in the industry including Agilent Technologies, Bio-Rad Laboratories, Bio-Techne, Danaher, GenScript, Illumina, Merck KGaA, New England Biolabs Inc, Revvity Inc, Thermo Fisher Scientific Inc, and others.
The gene silencing market is witnessing a significant trend toward the increasing adoption of RNA interference (RNAi) technology in precision medicine. RNAi-based therapeutics, including small interfering RNA (siRNA) and microRNA (miRNA), are being actively developed to target specific disease-related genes with high accuracy. This trend is particularly prominent in the treatment of genetic disorders, neurodegenerative diseases, and rare cancers. With the success of FDA-approved RNAi drugs such as patisiran and givosiran, pharmaceutical companies are accelerating their investment in gene silencing therapies. Additionally, the growing use of CRISPR interference (CRISPRi) for transient gene knockdown is expanding the scope of gene silencing, enabling precise regulation of gene expression in drug discovery and functional genomics research.
The increasing prevalence of genetic and chronic diseases is a major driver of the gene silencing market. With a growing number of patients suffering from conditions such as cancer, cardiovascular diseases, and neurological disorders, there is rising demand for targeted and personalized therapies. Gene silencing offers the potential to treat these diseases at the molecular level by blocking the expression of faulty or disease-associated genes. Additionally, the expanding focus on rare and orphan diseases is driving interest in gene silencing therapies, as they offer promising solutions for conditions with limited treatment options. The rising incidence of viral infections, including hepatitis B and HIV, is also boosting demand for antiviral gene silencing strategies, which aim to suppress viral replication by targeting essential genes.
A significant opportunity in the gene silencing market lies in its expanding application in agriculture and veterinary medicine. In agriculture, gene silencing techniques such as RNAi are being used to develop pest-resistant and disease-tolerant crops, reducing the need for chemical pesticides. Additionally, gene silencing is being explored for controlling viral infections in livestock and improving animal health. RNA-based veterinary therapeutics targeting pathogens and parasites are gaining attention for their potential to reduce antibiotic use and enhance animal productivity. With the increasing demand for sustainable farming practices and food security, the application of gene silencing in crop protection and animal health presents substantial growth potential.
The Drug Discovery & Development segment is the largest application in the Gene Silencing Market due to the increasing use of gene silencing techniques in identifying and validating therapeutic targets. Pharmaceutical and biotech companies extensively apply gene silencing, including RNA interference (RNAi) and antisense oligonucleotides (ASOs), to study gene function and develop novel therapies for genetic disorders, cancer, and infectious diseases. The rising demand for precision medicine and personalized treatments further drives the adoption of gene silencing in drug discovery. Additionally, the growing number of clinical trials leveraging gene-silencing technologies strengthens this segment’s dominance, making it the primary revenue generator.
The Pharmaceutical & Biotechnology Companies segment is projected to be the fastest-growing end-user in the Gene Silencing Market through 2034, driven by the increasing adoption of RNA interference (RNAi) and antisense oligonucleotide (ASO) technologies for therapeutic development. Pharmaceutical companies are actively investing in gene silencing-based drug discovery and development to target genetic disorders, viral infections, and cancers. The rising prevalence of chronic and rare diseases is driving demand for gene-silencing therapies, contributing to the segment's rapid growth. Additionally, the increasing number of clinical trials and FDA approvals for RNAi-based drugs, along with partnerships between biotech firms and pharmaceutical giants, is boosting the market expansion. The focus on precision medicine, personalized therapies, and next-generation gene editing technologies makes Pharmaceutical & Biotechnology Companies the fastest-growing segment over the forecast period.
China's gene silencing market is driven by the country's rapidly expanding biotechnology and pharmaceutical sectors. The growing prevalence of genetic disorders, cancer, and chronic diseases is fueling the demand for gene silencing therapies, including RNA interference (RNAi) and antisense oligonucleotides (ASOs). Additionally, the government's significant investments in genomics research and precision medicine are promoting the development of gene silencing technologies. China’s increasing focus on personalized medicine and gene-editing applications is accelerating clinical trials and drug development in this field. Collaborations between biotech companies, research institutes, and academic centers are further boosting innovation. The country’s growing biopharma industry and rising healthcare expenditure are supporting market expansion.
India's gene silencing market is expanding due to the increasing prevalence of genetic diseases, including cancer, cardiovascular conditions, and rare disorders. The rising demand for advanced gene therapy solutions is driving the adoption of gene silencing technologies. The country’s growing biotechnology sector, supported by government initiatives and funding, is fostering R&D activities in RNAi and gene-editing techniques. Additionally, the expansion of clinical research organizations (CROs) and pharmaceutical companies is promoting the development of gene silencing-based therapeutics. India’s increasing focus on precision medicine and the application of gene silencing in drug discovery and disease modeling is further driving market growth.
The US gene silencing market is driven by the country’s strong biotechnology and pharmaceutical ecosystem. The rising incidence of cancer, neurological disorders, and genetic diseases is fueling the demand for gene silencing therapies. The growing adoption of RNA interference (RNAi) and antisense oligonucleotides (ASOs) in drug development is accelerating market growth. Additionally, the US FDA’s approvals of gene silencing-based drugs, such as siRNA therapeutics, are promoting commercialization. Increasing R&D investments by biotech firms, along with academic collaborations, are driving innovation in gene silencing technologies. The expansion of personalized medicine and the growing focus on rare disease treatments are further boosting market growth.
Germany’s gene silencing market is expanding due to the country’s strong biotechnology and pharmaceutical industries. The rising demand for targeted therapies to treat genetic disorders and cancer is fueling market growth. Additionally, Germany's significant investments in genomics research and gene-editing technologies are driving the development of gene silencing solutions. The country’s focus on precision medicine and personalized therapies is promoting the adoption of RNAi and antisense-based treatments. Collaborations between biotech companies, research institutions, and pharmaceutical firms are fostering clinical trials and the commercialization of gene silencing-based drugs. Increasing government funding for rare disease research is further supporting market expansion.
France’s gene silencing market is driven by the country’s growing biotechnology and pharmaceutical sectors. The increasing incidence of cancer, rare genetic disorders, and neurodegenerative diseases is boosting the demand for gene silencing-based therapies. The country’s strong focus on genomics research and precision medicine is promoting R&D in RNAi and antisense oligonucleotide (ASO) technologies. Additionally, France’s biopharma companies are actively investing in clinical trials and drug development involving gene silencing applications. The government’s support for rare disease research and orphan drug development is further driving market expansion. Growing collaborations between biotech startups and academic institutions are fostering innovation in gene silencing technologies.
The Middle East gene silencing market is growing due to the rising prevalence of genetic disorders and chronic diseases. Countries such as the UAE and Saudi Arabia are investing in precision medicine and genomics research, driving the adoption of gene silencing technologies. The increasing focus on rare disease treatment and personalized medicine is promoting the use of RNAi and antisense oligonucleotide therapies. Additionally, collaborations between regional healthcare institutions and global biotech firms are fostering clinical trials and R&D activities. The expanding healthcare infrastructure and government initiatives to support advanced therapeutics are further boosting market growth. Increasing investments in biotech startups and research centers are also driving innovation in the gene silencing market.
|
Parameter |
Details |
|
Market Size (2025) |
$10 Billion |
|
Market Size (2034) |
$28.9 Billion |
|
Market Growth Rate |
12.5% |
|
Segments |
By Product & Service (Products, Services), By Application (Drug Discovery & Development, Therapeutics Manufacturing, Agricultural Applications, Others), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others) |
|
Study Period |
2019- 2024 and 2025-2034 |
|
Units |
Revenue (USD) |
|
Qualitative Analysis |
Porter’s Five Forces, SWOT Profile, Market Share, Scenario Forecasts, Market Ecosystem, Company Ranking, Market Dynamics, Industry Benchmarking |
|
Companies |
Agilent Technologies, Bio-Rad Laboratories, Bio-Techne, Danaher, GenScript, Illumina, Merck KGaA, New England Biolabs Inc, Revvity Inc, Thermo Fisher Scientific Inc |
|
Countries |
US, Canada, Mexico, Germany, France, Spain, Italy, UK, Russia, China, India, Japan, South Korea, Australia, South East Asia, Brazil, Argentina, Middle East, Africa |
By Product & Service
Products
-RNAi
-CRISPR-Cas9
-Antisense Oligonucleotides
Services
By Application
Drug Discovery & Development
-Neurology
-Oncology
-Infectious Diseases
-Metabolic Diseases
Therapeutics Manufacturing
Agricultural Applications
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
CROs & CMOs
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Agilent Technologies
Bio-Rad Laboratories
Bio-Techne
Danaher
GenScript
Illumina
Merck KGaA
New England Biolabs Inc
Revvity Inc
Thermo Fisher Scientific Inc
*- List Not Exhaustive
About USD Analytics
Table of Contents
List of Charts and Exhibits
List of Tables
1. Executive Summary
What’s New in 2025?
Top 10 Takeaways from the industry
Potential Opportunities for Industry Stakeholders
Strategic Imperatives
Company Market Positioning
Industry Benchmarking Matrix
2. Research Scope and Methodology
Market Definition
- Market Segments
- Companies Profiled
Research Methodology
- Bottom-Up Method
- Top-Down Method
- Data Triangulation
Forecast Methodology
- Data Sources
- USDA Proprietary Databases
- External Sources
- Primary Research and Interviews
Conversion Rates for USD
Abbreviations
3. Strategic Landscape: Key Insights and Implications
Spotlight: Key Strategies opted by Business Leaders
Competitive Landscape
Market Size ($ Million) and Share (%) by Company, 2024
SWOT Analysis
- Key Market Strengths
- Key Market Weaknesses
- Potential Opportunities
- Potential Threats
Porter’s Five Force Analysis
- Summary
- Bargaining Power of Buyers- Impact Analysis
- Bargaining Power of Suppliers- Impact Analysis
- Threat of new entrants- Impact Analysis
- Intensity of Competitive Rivalry- Impact Analysis
Macro-Environmental Analysis
- Economic forecasts by Country, 2010- 2035
- Population forecasts by Country, 2010- 2035
- Inflation Outlook by Country, 2010-2035
- Impact of Russia-Ukraine Conflict, Sluggish China Growth, US Developments
5. Growth Opportunity Analysis
Trends at a Glance
- What are the most noteworthy trends in the market
- Where should leaders pay attention?
- What industries are likely to be affected by the growth?
Market Dynamics
- Charting a path forward
- Growth Drivers
- Growth Barriers
Key Industry Stakeholders
- Suppliers
- Manufacturers and Service Providers
- Distribution Channels
- End-Users and Applications
- Regulators
- Investors, Traders, and R&D Institutes
Regulatory Landscape
6. Market Size Outlook to 2034
Global Gene Silencing Market Size Forecast, USD Million, 2018- 2034
- Historic Market Size, 2018- 2024
- Forecast Market Size, 2024- 2034
Scenario Analysis
- Low Growth Scenario: Definition and Outlook to 2034
- Reference Case: Definition and Outlook to 2034
- High Growth Scenario: Definition and Outlook to 2034
Pricing Analysis and Outlook
- Gene Silencing Average Price Forecast, 2021- 2034
- Key Factors Shaping the Pricing Patterns
7. Historical Gene Silencing Market Size by Segments, 2018- 2024
Key Statistics, 2024
Gene Silencing Market Size Outlook by Type, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Gene Silencing Types, 2018- 2024
Gene Silencing Market Size Outlook by Application, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Gene Silencing Applications, 2018- 2024
8. Gene Silencing Market Size Outlook by Segments, 2024- 2034
By Product & Service
Products
-RNAi
-CRISPR-Cas9
-Antisense Oligonucleotides
Services
By Application
Drug Discovery & Development
-Neurology
-Oncology
-Infectious Diseases
-Metabolic Diseases
Therapeutics Manufacturing
Agricultural Applications
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
CROs & CMOs
Others
9. Gene Silencing Market Size Outlook by Region
North America
Key Market Dynamics
North America Gene Silencing Market Size Outlook by Type, USD Million, 2021-2034
North America Gene Silencing Market Size Outlook by Application, USD Million, 2021-2034
North America Gene Silencing Market Size Outlook by Sales Channel, USD Million, 2021-2034
North America Gene Silencing Market Size Outlook by Country, USD Million, 2021-2034
Europe
Key Market Dynamics
Europe Gene Silencing Market Size Outlook by Type, USD Million, 2021-2034
Europe Gene Silencing Market Size Outlook by Application, USD Million, 2021-2034
Europe Gene Silencing Market Size Outlook by Sales Channel, USD Million, 2021-2034
Europe Gene Silencing Market Size Outlook by Country, USD Million, 2021-2034
Asia Pacific
Key Market Dynamics
Asia Pacific Gene Silencing Market Size Outlook by Type, USD Million, 2021-2034
Asia Pacific Gene Silencing Market Size Outlook by Application, USD Million, 2021-2034
Asia Pacific Gene Silencing Market Size Outlook by Sales Channel, USD Million, 2021-2034
Asia Pacific Gene Silencing Market Size Outlook by Country, USD Million, 2021-2034
South America
Key Market Dynamics
South America Gene Silencing Market Size Outlook by Type, USD Million, 2021-2034
South America Gene Silencing Market Size Outlook by Application, USD Million, 2021-2034
South America Gene Silencing Market Size Outlook by Sales Channel, USD Million, 2021-2034
South America Gene Silencing Market Size Outlook by Country, USD Million, 2021-2034
Middle East and Africa
Key Market Dynamics
Middle East and Africa Gene Silencing Market Size Outlook by Type, USD Million, 2021-2034
Middle East and Africa Gene Silencing Market Size Outlook by Application, USD Million, 2021-2034
Middle East and Africa Gene Silencing Market Size Outlook by Sales Channel, USD Million, 2021-2034
Middle East and Africa Gene Silencing Market Size Outlook by Country, USD Million, 2021-2034
10. United States Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
United States Gene Silencing Market Size Outlook by Type, 2021- 2034
United States Gene Silencing Market Size Outlook by Application, 2021- 2034
United States Gene Silencing Market Size Outlook by End-User, 2021- 2034
11. Canada Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Canada Gene Silencing Market Size Outlook by Type, 2021- 2034
Canada Gene Silencing Market Size Outlook by Application, 2021- 2034
Canada Gene Silencing Market Size Outlook by End-User, 2021- 2034
12. Mexico Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Mexico Gene Silencing Market Size Outlook by Type, 2021- 2034
Mexico Gene Silencing Market Size Outlook by Application, 2021- 2034
Mexico Gene Silencing Market Size Outlook by End-User, 2021- 2034
13. Germany Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Germany Gene Silencing Market Size Outlook by Type, 2021- 2034
Germany Gene Silencing Market Size Outlook by Application, 2021- 2034
Germany Gene Silencing Market Size Outlook by End-User, 2021- 2034
14. France Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
France Gene Silencing Market Size Outlook by Type, 2021- 2034
France Gene Silencing Market Size Outlook by Application, 2021- 2034
France Gene Silencing Market Size Outlook by End-User, 2021- 2034
15. United Kingdom Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
United Kingdom Gene Silencing Market Size Outlook by Type, 2021- 2034
United Kingdom Gene Silencing Market Size Outlook by Application, 2021- 2034
United Kingdom Gene Silencing Market Size Outlook by End-User, 2021- 2034
16. Spain Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Spain Gene Silencing Market Size Outlook by Type, 2021- 2034
Spain Gene Silencing Market Size Outlook by Application, 2021- 2034
Spain Gene Silencing Market Size Outlook by End-User, 2021- 2034
17. Italy Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Italy Gene Silencing Market Size Outlook by Type, 2021- 2034
Italy Gene Silencing Market Size Outlook by Application, 2021- 2034
Italy Gene Silencing Market Size Outlook by End-User, 2021- 2034
18. Benelux Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Benelux Gene Silencing Market Size Outlook by Type, 2021- 2034
Benelux Gene Silencing Market Size Outlook by Application, 2021- 2034
Benelux Gene Silencing Market Size Outlook by End-User, 2021- 2034
19. Nordic Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Nordic Gene Silencing Market Size Outlook by Type, 2021- 2034
Nordic Gene Silencing Market Size Outlook by Application, 2021- 2034
Nordic Gene Silencing Market Size Outlook by End-User, 2021- 2034
20. Rest of Europe Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Europe Gene Silencing Market Size Outlook by Type, 2021- 2034
Rest of Europe Gene Silencing Market Size Outlook by Application, 2021- 2034
Rest of Europe Gene Silencing Market Size Outlook by End-User, 2021- 2034
21. China Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
China Gene Silencing Market Size Outlook by Type, 2021- 2034
China Gene Silencing Market Size Outlook by Application, 2021- 2034
China Gene Silencing Market Size Outlook by End-User, 2021- 2034
22. India Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
India Gene Silencing Market Size Outlook by Type, 2021- 2034
India Gene Silencing Market Size Outlook by Application, 2021- 2034
India Gene Silencing Market Size Outlook by End-User, 2021- 2034
23. Japan Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Japan Gene Silencing Market Size Outlook by Type, 2021- 2034
Japan Gene Silencing Market Size Outlook by Application, 2021- 2034
Japan Gene Silencing Market Size Outlook by End-User, 2021- 2034
24. South Korea Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
South Korea Gene Silencing Market Size Outlook by Type, 2021- 2034
South Korea Gene Silencing Market Size Outlook by Application, 2021- 2034
South Korea Gene Silencing Market Size Outlook by End-User, 2021- 2034
25. Australia Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Australia Gene Silencing Market Size Outlook by Type, 2021- 2034
Australia Gene Silencing Market Size Outlook by Application, 2021- 2034
Australia Gene Silencing Market Size Outlook by End-User, 2021- 2034
26. South East Asia Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
South East Asia Gene Silencing Market Size Outlook by Type, 2021- 2034
South East Asia Gene Silencing Market Size Outlook by Application, 2021- 2034
South East Asia Gene Silencing Market Size Outlook by End-User, 2021- 2034
27. Rest of Asia Pacific Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Asia Pacific Gene Silencing Market Size Outlook by Type, 2021- 2034
Rest of Asia Pacific Gene Silencing Market Size Outlook by Application, 2021- 2034
Rest of Asia Pacific Gene Silencing Market Size Outlook by End-User, 2021- 2034
28. Brazil Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Brazil Gene Silencing Market Size Outlook by Type, 2021- 2034
Brazil Gene Silencing Market Size Outlook by Application, 2021- 2034
Brazil Gene Silencing Market Size Outlook by End-User, 2021- 2034
29. Argentina Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Argentina Gene Silencing Market Size Outlook by Type, 2021- 2034
Argentina Gene Silencing Market Size Outlook by Application, 2021- 2034
Argentina Gene Silencing Market Size Outlook by End-User, 2021- 2034
30. Rest of South America Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of South America Gene Silencing Market Size Outlook by Type, 2021- 2034
Rest of South America Gene Silencing Market Size Outlook by Application, 2021- 2034
Rest of South America Gene Silencing Market Size Outlook by End-User, 2021- 2034
31. United Arab Emirates Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
United Arab Emirates Gene Silencing Market Size Outlook by Type, 2021- 2034
United Arab Emirates Gene Silencing Market Size Outlook by Application, 2021- 2034
United Arab Emirates Gene Silencing Market Size Outlook by End-User, 2021- 2034
32. Saudi Arabia Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Saudi Arabia Gene Silencing Market Size Outlook by Type, 2021- 2034
Saudi Arabia Gene Silencing Market Size Outlook by Application, 2021- 2034
Saudi Arabia Gene Silencing Market Size Outlook by End-User, 2021- 2034
33. Rest of Middle East Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Middle East Gene Silencing Market Size Outlook by Type, 2021- 2034
Rest of Middle East Gene Silencing Market Size Outlook by Application, 2021- 2034
Rest of Middle East Gene Silencing Market Size Outlook by End-User, 2021- 2034
34. South Africa Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
South Africa Gene Silencing Market Size Outlook by Type, 2021- 2034
South Africa Gene Silencing Market Size Outlook by Application, 2021- 2034
South Africa Gene Silencing Market Size Outlook by End-User, 2021- 2034
35. Rest of Africa Gene Silencing Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Africa Gene Silencing Market Size Outlook by Type, 2021- 2034
Rest of Africa Gene Silencing Market Size Outlook by Application, 2021- 2034
Rest of Africa Gene Silencing Market Size Outlook by End-User, 2021- 2034
36. Key Companies
Market Share Analysis
Agilent Technologies
Bio-Rad Laboratories
Bio-Techne
Danaher
GenScript
Illumina
Merck KGaA
New England Biolabs Inc
Revvity Inc
Thermo Fisher Scientific Inc
Company Benchmarking
Financial Analysis
37. Recent Market Developments
38. Appendix
Looking Ahead
Research Methodology
Legal Disclaimer
By Product & Service
Products
-RNAi
-CRISPR-Cas9
-Antisense Oligonucleotides
Services
By Application
Drug Discovery & Development
-Neurology
-Oncology
-Infectious Diseases
-Metabolic Diseases
Therapeutics Manufacturing
Agricultural Applications
Others
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
CROs & CMOs
Others
The Global Gene Silencing Market Size is estimated at $10 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 12.5% to reach $28.9 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Agilent Technologies, Bio-Rad Laboratories, Bio-Techne, Danaher, GenScript, Illumina, Merck KGaA, New England Biolabs Inc, Revvity Inc, Thermo Fisher Scientific Inc
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume